appointed as Assistant Professor. He studied a mouse model of alcohol abuse, and then went for a year to work with Julius Axelrod at NIH. Subsequently he was on faculty at UC Irvine 1969 -1981 as Professor of Psychiatry, Psychobiology and Pharmacology, before being recruited to UCLA.
Besides his advocacy of public awareness of fetal alcohol syndrome, Ernie was most known for his research to determine genetically directed vulnerabilities to alcoholism. In July 1991, he and colleagues reported in Archives of General Psychiatry that a variant in a gene related to D2 dopamine receptors, labeled the DRD2 A1 allele, produced reduced numbers of D2 receptors, whether a person was alcoholic or not, and had an increased likelihood of becoming alcoholic. They hypothesized that this A1 allele led to a state of "reward deficiency," and subsequently provided evidence suggesting that it could also be involved in nicotine, opiate, and cocaine addictions, and even in over-eating. Although there was much resistance to this evidence for genetic, biological factors in addictions from those adamant that these are moral and/or socially induced afflictions, subsequent research in other laboratories has supported this notion that having this A1 allele increases the likelihood of addictions, as well as impulsecontrol problems. Dr. Noble and colleagues also published in Nature Medicine in 1995 a study showing that the dopamine agonist, bromocriptine, reduced craving and anxiety in alcoholics with this DRD2 A1 allele. Thus, Ernie and his many colleagues were among the first to provide evidence that led to the explosion of research and general interest in genetic factors in addictions, leading in turn to the promise of new, improved treatments.
Ernie always credited the phenomenal mentorship he had in developing his career, and it is no fluke that he paid the debt back by mentoring and sponsoring many students. Although never doing direct research with him, I frequently sought his advice about a number of research and academic/political issues and quandaries, and he was always available to listen and give his best-considered and principled advice. I always found him of remarkable good humor, and quite self-effacing. Indeed, few knew that in addition to all his other credits, Ernie was an accomplished opera singer, having sung in Carnegie Hall as a youth, and later while on a sabbatical in France, as the lead baritone role in Carmen and Aida at the Strasbourg Opera House.
Ernie is missed as one of such diverse talents, drive, and dedication, now increasingly rare, but memorialized as a physician-scientist who accomplished a variety of feats of considerable significance and lasting importance.
